Try our mobile app
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
South African income tax number: 9432434182
(‘Mediclinic’, the ‘Company’, or the ‘Group’)
25 May 2023
NOTIFICATION: TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES & PERSONS CLOSELY ASSOCIATED WITH THEM
Vesting of awards under the Company's Short-Term Incentive (‘STI’) scheme and Long-Term
Incentive Plan (‘LTIP’)
In connection with the recommended cash acquisition of Mediclinic by Manta Bidco Limited (a newly
formed company owned by: (i) Remgro Limited and certain of its subsidiaries; and (ii) SAS Shipping
Agencies Services S.à r.l., a wholly owned subsidiary of MSC Mediterranean Shipping Company SA)
(the ‘Acquisition’), this notification sets out the details of the vesting of awards over ordinary shares in
Mediclinic granted under the Company’s STI and LTIP to Directors and other persons discharging
managerial responsibilities (‘PDMRs’) in the financial years ended on 31 March 2020, 31 March 2021,
31 March 2022 and 31 March 2023.
The awards vested on 24 May 2023 and will be settled in cash, based on the offer price to be paid by
Manta Bidco Limited in connection with the Acquisition, being 501 pence per share.
The notifications that follow are made in accordance with Articles 19.1 and 19.3 of the Market Abuse
Regulation.
1. Details of PDMR / person closely associated with them
a) Name Dr Carel Aron van der Merwe
2. Reason for the notification
a) Position / status Group Chief Executive Officer – Mediclinic International plc
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4.1 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 19 June 2019;
2. 14 December 2020;
3. 4 June 2021; and
4. 5 August 2022.
Vesting of deferred awards over ordinary shares in Mediclinic
granted at nil cost under the Company’s STI on:
5. 4 June 2021; and
6. 5 August 2022
c) Price(s) and
volume(s) Price(s) Volume(s)
1. £nil 45 185
2. £nil 176 093
3. £nil 118 727
4. £nil 49 524
5. £nil 122 614
6. £nil 74 718
d) Aggregated
information
Aggregated volume 586 861
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Petrus Jurgens Myburgh
2. Reason for the notification
a) Position / status Group Chief Financial Officer – Mediclinic International plc
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4.1 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 19 June 2019;
2. 14 December 2020;
3. 4 June 2021; and
4. 5 August 2022.
Vesting of deferred awards over ordinary shares in Mediclinic
granted at nil cost under the Company’s STI on:
5. 4 June 2021; and
6. 5 August 2022
c) Price(s) and
volume(s) Price(s) Volume(s)
1. £nil 24 981
2. £nil 97 549
3. £nil 63 523
4. £nil 30 900
5. £nil 80 655
6. £nil 47 488
d) Aggregated
information
Aggregated volume 345 096
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Gert Cornelis Hattingh
2. Reason for the notification
a) Position / status Group Chief Governance Officer – Mediclinic International plc
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
c) Price(s) and
volume(s) Price(s) Volume(s)
1. £nil 37 839
2. £nil 24 331
3. £nil 5 983
d) Aggregated
information
Aggregated volume 68 153
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Dr Dirk Cornelius le Roux
2. Reason for the notification
a) Position / status Group Chief Information Officer – Mediclinic International plc
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
c) Price(s) and
volume(s) Price(s) Volume(s)
1. £nil 29 654
2. £nil 19 053
3. £nil 4 677
d) Aggregated
information
Aggregated volume 53 384
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Dr Daniel Liedtke
2. Reason for the notification
a) Position / status Chief Executive Officer: Hirslanden
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
c) Price(s) and
volume(s) Price(s) Volume(s)
1. £nil 70 352
2. £nil 39 423
3. £nil 10 849
d) Aggregated
information
Aggregated volume 120 624
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Magnus Oetiker
2. Reason for the notification
a) Position / status Group Chief Strategy Officer – Mediclinic International plc
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
c) Price(s) and
volume(s) Price(s) Volume(s)
1. £nil 56 587
2. £nil 32 303
3. £nil 10 822
d) Aggregated
information
Aggregated volume 99 712
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Koert Hendrik Stefanus Pretorius
2. Reason for the notification
a) Position / status Group Chief Operating Officer – Mediclinic International plc
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
c) Price(s) and
volume(s) Price(s) Volume(s)
1. £nil 39 509
2. £nil 25 469
3. £nil 6 261
d) Aggregated
information
Aggregated volume 71 239
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Dr René Toua
2. Reason for the notification
a) Position / status Group Chief Clinical Officer – Mediclinic International plc
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
c) Price(s) and
volume(s) Price(s) Volume(s)
1. £nil 30 301
2. £nil 19 829
3. £nil 4 915
d) Aggregated
information
Aggregated volume 55 045
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Dr Tyson Bruno Welzel
2. Reason for the notification
a) Position / status Group Chief Innovation Officer – Mediclinic International plc
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
c) Price(s) and
volume(s) Price(s) Volume(s)
1. £nil 24 080
2. £nil 15 896
3. £nil 8 460
d) Aggregated
information
Aggregated volume 48 436
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Hein van Eck
2. Reason for the notification
a) Position / status Chief Executive Officer – Mediclinic Middle East
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
4. 14 December 2020;
5. 4 June 2021; and
6. 5 August 2022.
c) Price(s) and
volume(s) Price(s) Volume(s)
4. £nil 8 833
5. £nil 5 011
6. £nil 2 102
d) Aggregated
information
Aggregated volume 15 946
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
1. Details of PDMR / person closely associated with them
a) Name Greg van Wyk
2. Reason for the notification
a) Position / status Chief Executive Officer: Mediclinic Southern Africa
b) Initial notification / Initial Notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary Shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Vesting of conditional awards over ordinary shares in Mediclinic
transaction granted at nil cost under the Company’s LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
c) Price(s) and
volume(s) Price(s) Volume(s)
4. £nil 22 919
5. £nil 14 800
6. £nil 5 681
d) Aggregated
information
Aggregated volume 43 400
Price £nil
e) Date of the 24 May 2023
transaction
f) Place of the Outside a trading venue
transaction
CONTACT INFORMATION
Investor queries
James Arnold, Head of Investor Relations, Mediclinic International plc
+44 (0)20 3786 8181
ir@mediclinic.com
Media queries
FTI Consulting
Ben Atwell/Ciara Martin – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd
